Mount Sinai Health System in New York City is forcing part-time physicians to sign employment contracts that violate their ...

A test intended to guide treatment decisions on weight loss options, including costly GLP-1 drugs, may be a step toward ...

Those who treat and research long COVID warn that viral persistence and reactivation are real risks for some patients.

A threshold of sustained lupus low disease activity state (LLDAS) or remission for 3 months significantly reduces the risk ...

Researchers conducted a retrospective cohort study using an Israeli administrative claims database in which they analyzed the ...

Counterfeit Ozempic products surfaced in Germany's official supply chain in October 2023, as reported by Medscape Medical ...

Eight commonly used antidepressants have been ranked by their weight gain potential.

Experts make cases for prioritizing obesity, complications, remission, or glucose, grappling with sometimes conflicting ...

Mounting evidence suggested Lp(a) has prothrombotic properties, prompting interest in low-dose aspirin to mitigate risk. That ...

Europe's drug authorities warn that off-label use is exacerbating shortages and placing the public at risk for serious harm.

Observational survey finds over 30% still don't reach A1c < 7.0%, and one in five continue to experience severe hypoglycemia.

One year of adjuvant therapy with dabrafenib plus trametinib was associated with a 20% lower risk for death than placebo — ...